FMP

FMP

Enter
API Tools
API DocumentationAPI ViewerAPI DocumentationLegacyAPI ViewerLegacy
Pricing
Blog
How To
Education
Index ArticlesForexFinancial RatiosCryptoFinancial AnalysisOther
Market NewsDiscounted Cash FlowDeveloper
Screener
Most Searched StocksForeign Exchange RatesCryptocurrenciesMarket IndexesMarket Top GainersMarket Top LosersMarket Highest VolumeSector Performance
Extras
Resources
Formula Methodologies
Financial FormulasParsing StatementsDCF FormulaPiotroski ScoreOwner EarningsRecommendations Formula
Excel/Sheets Add-on
Excel Add-onGoogle Sheet Add-on
API Updates
ChangelogAPI StatusCycle Times
CareersAffiliate ProgramFAQs
Sign InSign Up

RGMP - Regnum Corp.

photo-url-https://images.financialmodelingprep.com/symbol/RGMP.png

Regnum Corp.

RGMP

PNK

Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C—C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company is based in New York, New York. Regnum Corp. is a subsidiary of Phoenixus AG.

0.0001 USD

3.0000000015651188e-12 (0.000003%)

OverviewProfileFinancial StatementsFinancial RatiosChartAnalysisNewsCorporate ActionsDCF

Valuation Date:

Mar 17, 2025 4:00 PM

Share Price on Valuation Date

$0

Stock Beta

2.907

Shares Outstanding

22950000

FMP

FMP

FMP

HomeTerms of ServicePrivacy PolicyBlogCareersFAQsContact Us

API

DocumentationPricingFormulasMarket Indexes
Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep